Perika St. John's Wort
- St. John's WortCategory D
LiverTox Category D. Few case reports of hepatitis; causality uncertain. Major drug-interaction concern (CYP3A4 induction) — can reduce levels of warfarin, oral contraceptives, immunosuppressants, HIV antivirals.
LiverTox →
Supplement Facts
2 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Vitamin C vitaminUNII · PQ6CK8PD0R UL · set5 effects | 4 mg | 7% |
| St. John's Wort extract St. John's WortherbUNII · UFH8805FKA LiverTox D | 300 mg | — |
5 authority-backed effects
Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.
- from: Vitamin C
- from: Vitamin C
- from: Vitamin C
- from: Vitamin C
- from: Vitamin C
1 flagged · authority citations
- ● AVOIDTitanium Dioxidecolor
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →
Cellulose · Starch · modified Cellulose Gum · Modified Cellulose · Caramel · Silica · Magnesium Stearate · Stearic Acid